Moderna to supply 40M COVID-19 vaccines to Korea
Jan. 16, 2020
Global Korean Post
By Yoon Sojung
The U.S. pharmaceutical company Moderna on Dec. 29 officially announced that it will start supplying from next year’s second quarter 40 million doses of COVID-19 vaccines to Korea good for 20 million people.
This is the double the volume originally agreed by the government and Moderna in their contract. The supply schedule was also moved up to the second quarter from the third.
In a news release, Moderna said, “The company is engaged in discussions with the government of South Korea to potentially provide 40 million or more doses of the Moderna COVID-19 Vaccine to support South Korea’s aim of providing vaccines to the public as soon as possible.”
“Under the terms of the proposed agreement, distribution would begin in the second quarter of 2021.”
Moderna’s official announcement followed a videoconference on the same day between President Moon Jae-in and the company’s CEO Stephen Bancel.
In a 27-minute conversation that started at 9:53 p.m. CEO Bancel told the president that he will do his best to enable early supply of the vaccines, adding that the contract can be signed within the year if the Korean government wants an early conclusion.
President Moon congratulated the executive on the success of Moderna’s vaccine and earning emergency approval for use. The president also said he hopes for an early signing of the agreement before year’s end.
The increased supply of Moderna vaccines will lower their prices, and this deal means Korea has secured vaccines for 56 million people given its contracts for 36 million doses with the company and other suppliers, Cheong Wa Dae said.